PTCH mutations and deletions in patients with typical nevoid basal cell carcinoma syndrome and in patients with a suspected genetic predisposition to basal cell carcinoma: A French study

British Journal of Cancer

Volumn 95, Issue 4, 2006, Pages 548-553

  Soufir, N ^a   Gerard, B ^a   Portela, M ^a   Brice, A ^a   Liboutet, M ^b   Saiag, P ^c   Descamps, V ^a   Kerob, D ^b   Wolkenstein, P ^d   Gorin, I ^e   Lebbe, C ^b   Dupin, N ^e   Crickx, B ^a   Basset Seguin, N ^b   Grandchamp, B ^a  

^a BICHAT HOSPITAL   (France)

^b SAINT LOUIS HOSPITAL   (France)

^c HÔPITAL AMBROISE PARÉ   (France)

^d HENRI MONDOR HOSPITAL   (France)

^e Hôpital Bichat Claude Bernard ^*  (France)

Author keywords

Deletion; Multiple basal cell carcinoma; NBCCS; PATCHED

Indexed keywords

GENOMIC DNA; PROTEIN PATCHED;

5' UNTRANSLATED REGION; ADULT; ARTICLE; BASAL CELL CARCINOMA; BASAL CELL NEVUS SYNDROME; CONTROLLED STUDY; DNA POLYMORPHISM; FAMILIAL CANCER; FRAMESHIFT MUTATION; FRANCE; GENE; GENE DELETION; GENE MUTATION; GENETIC PREDISPOSITION; GERM LINE; HUMAN; HUMAN CELL; LEUKOCYTE; MAJOR CLINICAL STUDY; MICROSATELLITE MARKER; MUTATION RATE; NONSENSE MUTATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PTCH GENE; REAL TIME POLYMERASE CHAIN REACTION;

BASAL CELL NEVUS SYNDROME; CARCINOMA, BASAL CELL; FRANCE; GENE DELETION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MICROSATELLITE REPEATS; MUTATION; RECEPTORS, CELL SURFACE; SKIN NEOPLASMS;

EID: 33747162695     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6603303     Document Type: Article

References (31)

1. Aboulkassim TO, LaRue H, Lemieux P, Rousseau F, Fradet Y (2003) Alteration of the PATCHED locus in superficial bladder cancer. Oncogene 22: 2967-2971
2. Asplund A, Gustafsson AC, Wikonkal NM, Sela A, Leffell DJ, Kidd K, Lundeberg J, Brash DE, Ponten F (2005) PTCH codon 1315 polymorphism and risk for nonmelanoma skin cancer. Br J Dermatol 152: 868-873
3. Boonen SE, Stahl D, Kreiborg S, Rosenberg T, Kalscheuer V, Larsen LA, Tommerup N, Brondum-Nielsen K, Tumer Z (2005) Delineation of an interstitial 9q22 deletion in basal cell nevus syndrome. Am J Med Genet A 132: 324-328
4. Boutet N, Bignon YJ, Drouin-Garraud V, Sarda P, Longy M, Lacombe D, Gorry P (2003) Spectrum of PTCH1 mutations in French patients with Gorlin syndrome. J Invest Dermatol 121: 478-481
5. Chidambaram A, Goldstein AM, Gailani MR, Gerrard B, Bale SJ, DiGiovanna JJ, Bale AE, Dean M (1996) Mutations in the human homologue of the Drosophila patched gene in Caucasian and African-American nevoid basal cell carcinoma syndrome patients. Cancer Res 56: 4599-4601
6. den Dunnen JT, Antonarakis SE (2001) Nomenclature for the description of human sequence variations. Hum Genet 109: 121-124
7. Evans DG, Farndon PA, Burnell LD, Gattamaneni HR, Birch JM (1991) The incidence of Gorlin syndrome in 173 consecutive cases of medulloblastoma. Br J Cancer 64: 959-961
8. Farndon PA, Del Mastro RG, Evans DGR, Kilpatrick MW (1992) Location of gene for Gorlin syndrome. Lancet 339: 581-582
9. Fujii K, Kohno Y, Sugita K, Nakamura M, Moroi Y, Urabe K, Furue M, Yamada M, Miyashita T (2003) Mutations in the human homologue of Drosophila patched in Japanese nevoid basal cell carcinoma syndrome patients. Hum Mutat 21: 451-452
10. Gailani MR, Bale SJ, Leffell DJ, DiGiovanna JJ, Peck GL, Poliak S, Drum MA, Pastakia B, McBride OW, Kase R, Greene M, Mulvihill JJ, Bale AE (1992) Developmental defects in Gorlin syndrome related to a putative tumor suppressor gene on chromosome 9. Cell 69: 111-117
11. Gille JJ, Hogervorst FB, Pals G, Wijnen JT, van Schooten RJ, Dommering CJ, Meijer GA, Craanen ME, Nederlof PM, de Jong D, McElgunn CJ, Schouten JP, Menko FH (2002) Genomic deletions of MSH2 and MLH1 in colorectal cancer families detected by a novel mutation detection approach. Br J Cancer 87: 892-897
12. Ginzinger DG (2002) Gene quantification using real-time quantitative PCR: an emerging technology hits the mainstream. Exp Hematol 30: 503-512
13. Gorlin RJ (2004) Nevoid basal cell carcinoma (Gorlin) syndrome. Genet Med 6: 530-539
14. Hahn H, Wicking C, Zaphiropoulous PG, Gailani MR, Shanley S, Chidambaram A, Vorechovsky I, Holmberg E, Unden AB, Gillies S, Negus K, Smyth I, Pressman C, Leffell DJ, Gerrard B, Goldstein AM, Dean M, Toftgard R, Chenevix-Trench G, Wainwright B, Bale AE (1996) Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 85: 841-851
15. Haniffa MA, Leech SN, Lynch SA, Simpson NB (2004) NBCCS secondary to an interstitial chromosome 9q deletion. Clin Exp Dermatol 29: 542-544
16. Johnson RL, Rothman AL, Xie J, Goodrich LV, Bare JW, Bonifas JM, Quinn AG, Myers RM, Cox DR, Epstein Jr EH, Scott MP (1996) Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science 272: 1668-1671
17. Kimonis VE, Mehta SG, Digiovanna JJ, Bale SJ, Pastakia B (2004) Radiological features in 82 patients with nevoid basal cell carcinoma (NBCC or Gorlin) syndrome. Genet Med 6: 495-502
18. Lo Muzio L, Nocini PF, Savoia A, Consolo U, Procaccini M, Zelante L, Pannone G, Bucci P, Dolci M, Bambini F, Solda P, Favia G (1999) Nevoid basal cell carcinoma syndrome. Clinical findings in 37 Italian affected individuals. Clin Genet 55: 34-40
19. Marsh A, Wicking C, Wainwright B, Chenevix-Trench G (2005) DHPLC analysis of patients with Nevoid Basal Cell Carcinoma Syndrome reveals novel PTCH missense mutations in the sterol-sensing domain. Hum Mutat 26: 283
20. Midro AT, Panasiuk B, Tumer Z, Stankiewicz P, Silahtaroglu A, Lupski JR, Zemanova Z, Stasiewicz-Jarocka B, Hubert E, Tarasow E, Famulski W, Zadrozna-Tolwinska B, Wasilewska E, Kirchhoff M, Kalscheuer V, Michalova K, Tommerup N (2004) Interstitial deletion 9q22.32-q33.2 associated with additional familial translocation t(9;17)(q34.11;p11.2) in a patient with Gorlin-Goltz syndrome and features of Nail-Patella syndrome. Am J Med Genet A 124: 179-191
21. Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16: 1215
22. Olivieri C, Maraschio P, Caselli D, Martini C, Beluffi G, Maserati E, Danesino C (2003) Interstitial deletion of chromosome 9, int del(9)(9q22.31-q31.2), including the genes causing multiple basal cell nevus syndrome and Robinow/brachydactyly 1 syndrome. Eur J Pediatr 162: 100-103
23. Reifenberger J, Wolter M, Weber RG, Megahed M, Ruzicka T, Lichter P, Reifenberger G (1998) Missense mutations in SMOH in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system. Cancer Res 58: 1798-1803
24. Sasaki K, Yoshimoto T, Nakao T, Minagawa K, Takahashi Y, Watanabe Y, Tanabe C (2000) A nevoid basal cell carcinoma syndrome with chromosomal aberration. No To Hattatsu 32: 49-55
25. Shanley S, Ratcliffe J, Hockey A, Haan E, Oley C, Ravine D, Martin N, Wicking C, Chenevix-Trench G (1994) Nevoid basal cell carcinoma syndrome: review of 118 affected individuals. Am J Med Genet 50: 282-290
26. Shimkets R, Gailani MR, Siu VM, Yang-Feng T, Pressman CL, Levanat S, Goldstein A, Dean M, Bale AE (1996) Molecular analysis of chromosome 9q deletions in two Gorlin syndrome patients. Am J Hum Genet 59: 417-422
27. Strange RC, El-Genidy N, Ramachandran S, Lovatt TJ, Fryer AA, Smith AG, Lear JT, Ichii-Jones F, Jones PW, Hoban PR (2004a) PTCH polymorphism is associated with the rate of increase in basal cell carcinoma numbers during follow-up: preliminary data on the influence of an exon 12-exon 23 haplotype. Environ Mol Mutagen 44: 469-476
28. Strange RC, El-Genidy N, Ramachandran S, Lovatt TJ, Fryer AA, Smith AG, Lear JT, Wong C, Jones PW, Ichii-Jones F, Hoban PR (2004b) Susceptibility to basal cell carcinoma: associations with PTCH polymorphisms. Ann Hum Genet 68: 536-545
29. Wicking C, Bale AE (1997) Molecular basis of the nevoid basal cell carcinoma syndrome. Curr Opin Pediatr 9: 630-635
30. Wicking C, Shanley S, Smyth I, Gillies S, Negus K, Graham S, Suthers G, Haites N, Edwards M, Wainwright B, Chenevix-Trench G (1997) Most germ-line mutations in the nevoid basal cell carcinoma syndrome lead to a premature termination of the PATCHED protein, and no genotype-phenotype correlations are evident. Am J Hum Genet 60: 21-26
31. Xie J, Murone M, Luoh SM, Ryan A, Gu Q, Zhang C, Bonifas JM, Lam CW, Hynes M, Goddard A, Rosenthal A, Epstein Jr EH, de Sauvage FJ (1998) Activating smoothened mutations in sporadic basal-cell carcinoma. Nature 391: 90-92